During the past decade, Hosp. Univ. Hm Monteprincipe conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hosp. Univ. Hm Monteprincipe" #1 sponsor was "Janssen Research & Development, LLC" with 8 trials, followed by "Gilead Sciences" with 1 trials sponsored, "Hansen Medical" with 1 trials sponsored, "Hipra Scientific, S.L.U" with 1 trials sponsored and "InspireMD" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hosp. Univ. Hm Monteprincipe" #1 collaborator was "Analyze & Realize" with 1 trials as a collaborator, "CIRION Central Laboratory" with 1 trials as a collaborator, "Dorevitch" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "ORION Clinical Services" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hosp. Univ. Hm Monteprincipe" are "Influenza A" (2 trials), "Urinary Bladder Neoplasms" (2 trials), "Abdominal Aortic Aneurysm" (1 trials), "Advanced Unresectable Pancreatic Cancer" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Hosp. Univ. Hm Monteprincipe" in a lesser frequency.

Most popular intervention types in "Hosp. Univ. Hm Monteprincipe" are "Drug" (10 trials), "Biological" (5 trials), "Other" (4 trials), "Device" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Carboplatin" (2 trials), "Cetrelimab" (2 trials), "Cisplatin" (2 trials) and "Etoposide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hosp. Univ. Hm Monteprincipe" are 14 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hosp. Univ. Hm Monteprincipe". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hosp. Univ. Hm Monteprincipe, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Hosp. Univ. Hm Monteprincipe, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".